{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:30:43Z","timestamp":1788481843501,"version":"build-2803163510"},"reference-count":105,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373725"],"award-info":[{"award-number":["82373725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Priority Academic Program Development of the Jiangsu Higher Education Institutes","award":["SGK1202403"],"award-info":[{"award-number":["SGK1202403"]}]},{"name":"Suzhou Science and Technology Development Plan Project","award":["SKY2023127"],"award-info":[{"award-number":["SKY2023127"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.1080\/13543776.2025.2467683","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T04:48:21Z","timestamp":1739594901000},"page":"515-532","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["P2Y\n            <sub>12<\/sub>\n            R antagonists in antithrombotic therapy: a patent and literature review (2019\u2013present)"],"prefix":"10.1080","volume":"35","author":[{"given":"Xin-Yu","family":"Chen","sequence":"first","affiliation":[{"name":"Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jia","sequence":"additional","affiliation":[{"name":"Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tian","family":"Kong","sequence":"additional","affiliation":[{"name":"Beijing University of Technology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-6893","authenticated-orcid":false,"given":"Huan-Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Soochow University","place":["Suzhou, China"]},{"name":"Suzhou Vocational Health College","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4767-6262","authenticated-orcid":false,"given":"Sheng","family":"Tian","sequence":"additional","affiliation":[{"name":"Soochow University","place":["Suzhou, China"]},{"name":"Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01558"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00046-5"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-014-4659-5"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.08.104"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2019.03.010"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20130162"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871525711311020005"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07467-1"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2011.03.001"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.10.007"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32832ea2f2"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-07-0581"},{"key":"e_1_3_7_15_1","unstructured":"R PP B RS S KJ. inventors; assignee. Modified release clopidogrel formulation.Patent WO2007113857. 2007."},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-011-0184-3"},{"key":"e_1_3_7_17_1","unstructured":"Brandt JT Farid NA J A J et al. Inventors; assignee. Dosage regimen for prasugrel in the treatment of vascular disease. Patent WO2006138317. 2006."},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12168"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12719"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000677"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2014.01.030"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071690"},{"key":"e_1_3_7_23_1","unstructured":"D EM E TR. Inventors; assignee. Preparation of 4-piperazinothieno[2 3-d]pyrimidines as P2Y12 receptor antagonists and platelet aggregation inhibitors. Patent WO2006103545. 2006."},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894x(96)00476-3"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-29423-5_7"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.09.021"},{"key":"e_1_3_7_27_1","unstructured":"Xu C Zhou X Weng Z. inventors; assignee. Application of P2Y12 receptor and its antagonist in diagnosis and treatment of acute pancreatitis. Patent CN113267636. 2021."},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704945"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G726"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicines5030093"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041845"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00416-9"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202103428"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201800550"},{"key":"e_1_3_7_35_1","unstructured":"Wang L Sun X Sun G et al. Inventors; assignee. Preparation of trifluoromethylpyrazole derivatives for preparing antiplatelet aggregation drugs. Patent CN110627723. 2019."},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090163"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.04.023"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm300038c"},{"key":"e_1_3_7_39_1","unstructured":"Huang C Zhang S Li L et al. Inventors; assignee. Thienopyridine derivative useful in treatment of cardiovascular diseases and preparation method. Patent WO2019037740. 2019."},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128969"},{"key":"e_1_3_7_41_1","unstructured":"Huang C Bi Y Huang Q. Inventors; assignee. Preparing method and application of tanshinone IIA thiophene pyridine compound. Patent CN110066310. 2019."},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.236034"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.joc.5b02011"},{"key":"e_1_3_7_44_1","unstructured":"Zhang H. Inventors; assignee. Biocatalyst and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds. Patent WO2019152679. 2019."},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202000109"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/acssynbio.9b00028"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2020.148276"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.03.060"},{"key":"e_1_3_7_49_1","unstructured":"H IA A CP D KN. inventors; assignee. Preparation of N-alkyl-2-substituted ATP analogs as platelet aggregation inhibitors. Patent WO9418216. 1994."},{"key":"e_1_3_7_50_1","unstructured":"A-C E E M EA Aastrand BM et al. Inventors; assignee. Method for treating ischemic event such as acute ischemic stroke in human. Patent WO2024089196. 2024."},{"key":"e_1_3_7_51_1","unstructured":"Du C Zhuang W. Inventors; assignee. Application of ticagrelor as pharmaceutical components in hepatitis drugs. Patent CN115089590. 2022."},{"key":"e_1_3_7_52_1","unstructured":"Wang G. Inventors; assignee. Application of ticagrelor in medicine for treating diabetic foot. Patent CN109908148. 2019."},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2018.1469371"},{"key":"e_1_3_7_54_1","unstructured":"Yang H Ye Y Li J et al. inventors; assignee. Preparation of ((difluorophenyl)cyclopropyl)aza-aromatic fused ring compounds pharmaceutical compositions as TREK-1 activators and their analgesic activity. Patent CN117003756. 2023."},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1159\/000166999"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1md00128k"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557511313070003"},{"key":"e_1_3_7_58_1","unstructured":"Zhang P Zhou X. Tong W et al. inventors; assignee. Pyrimidine-annulated triazole derivatives and their use in platelet aggregation inhibition. Patent WO2023108363. 2023."},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1160\/th10-05-0285"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy201"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.3997"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.4539"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2023.02.016"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00193"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094780"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2017.1356453"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.08.056"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704674"},{"key":"e_1_3_7_69_1","unstructured":"Lin J Zhang D Yang T. inventors; assignee. A kind of sd large rat plasma new compound wsj-557 for blood drug concentration quantitative analysis method. Patent CN108072712. 2018."},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01524"},{"key":"e_1_3_7_71_1","unstructured":"Ma S Zhao L Chen B. Inventors; assignee. Application of p2y1 conjugated p2y12 as target in screening anti-platelet aggregation drugs. Patent CN115995263. 2023."},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-0622-8110"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2016.1237381"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32835e98bf"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9010024"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120638"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/plants10061192"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134054"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.2478\/acph-2019-0050"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180417170218"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052311"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2022.116030"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.107034"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152571302151217142711"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.09.001"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116390"},{"key":"e_1_3_7_87_1","article-title":"Pyridine analogs as P2Y12 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of platelet aggregation disorders","author":"Andersen S","year":"2007","unstructured":"Andersen S, Bach P, Brickmann K, et al., inventors; assignee. Pyridine analogs as P2Y12 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of platelet aggregation disorders. Patent WO2007008140. 2007.","journal-title":"Patent WO2007008140"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400820m"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01971"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13083"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13288"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2020.1755670"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557514666141127143133"},{"key":"e_1_3_7_94_1","unstructured":"Li X Xu Z Li D et al. inventors; assignee. P2y12 receptor antagonist containing guanidyl and preparation method and use thereof. Patent WO2019149259. 2019."},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091114"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176399"},{"key":"e_1_3_7_97_1","unstructured":"Caroff E Fretz H Hilpert K et al. Inventors; assignee. Preparation of N-(4-pyrimidinylcarbonyl) amino acid piperazides and their use as P2Y12 receptor antagonists. Patent WO2006114774. 2006."},{"key":"e_1_3_7_98_1","unstructured":"Caroff E Hilpert K Meyer E. Inventors; assignee Preparation of N-(2-pyridylcarbonyl) amino acid piperazides and their use as P2Y12 receptor antagonists. Patent WO2008044217. 2008."},{"key":"e_1_3_7_99_1","unstructured":"Caroff E Meyer E. Inventors; assignee 2-Phenyl-4-cyclopropyl-pyrimidine derivatives as P2Y12 receptor antagonists and their preparation. Patent WO2009125365. 2009."},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1764533"},{"key":"e_1_3_7_101_1","unstructured":"Leuenberger D Reber S Von Raumer M. Inventors; assignee. Crystalline forms of phosphonopropionyl piperazinecarboxylate as P2Y12 receptor antagonists. Patent WO2018055016. 2018."},{"key":"e_1_3_7_102_1","unstructured":"Caroff E Hilpert K Hubler F et al. Inventors; assignee. Phosphonic acid derivatives and their use as P2Y12 receptor antagonists. Patent WO2009069100. 2009."},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1729121"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1646440"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12641"},{"key":"e_1_3_7_106_1","unstructured":"Buchmann S Fraichard A Herrmann C et al. inventors; assignee. Aqueous pharmaceutical composition comprising a P2Y12receptor antagonist. Patent WO2022013276. 2022."},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105743"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2467683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:16:36Z","timestamp":1746184596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2467683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,4]]}},"alternative-id":["10.1080\/13543776.2025.2467683"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2467683","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}